Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × Enzyme-Linked Immunosorbent Assay × Clear all

Status

Completed 6 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 17 Capecitabine 16 pertuzumab 15 Docetaxel 13 Cyclophosphamide 11 Carboplatin 11 pyrotinib 10 Paclitaxel 10 Letrozole 10 sacituzumab govitecan 8 Standard of Care 8 Radiotherapy 8 Fulvestrant 8 Drug Therapy 8 trastuzumab deruxtecan 7 eribulin 7 exemestane 6 dalpiciclib 6 abemaciclib 6 Tamoxifen 6 Epirubicin 6 Anastrozole 6 pembrolizumab 5 palbociclib 5 camrelizumab 4 Vinorelbine 4 Surveys and Questionnaires 4 Sentinel Lymph Node Biopsy 4 Neoadjuvant Therapy 4 Magnetic Resonance Spectroscopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06592560 2024-09-19

Asprosin in Breast Cancer

Assiut University

Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡